Unimark Remedies Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DRONEDARONE HYDROCHLORIDE, with a corresponding US DMF Number 25669.
Remarkably, this DMF maintains an Active status since its submission on February 16, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 30, 2013, and payment made on June 24, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II